Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-26 05:36:16 UTC |
---|
Update Date | 2016-11-09 01:21:16 UTC |
---|
Accession Number | CHEM035245 |
---|
Identification |
---|
Common Name | Inositol 1,4,5-trisphosphate |
---|
Class | Small Molecule |
---|
Description | Intracellular messenger formed by the action of phospholipase C on phosphatidylinositol 4,5-bisphosphate, which is one of the phospholipids that make up the cell membrane. Inositol 1,4,5-trisphosphate is released into the cytoplasm where it releases calcium ions from internal stores within the cell's endoplasmic reticulum. These calcium ions stimulate the activity of B kinase or calmodulin. |
---|
Contaminant Sources | |
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
1,4,5-Insp3 | ChEBI | D-Myo-inositol 1,4,5-trisphosphate | ChEBI | D-MYO-inositol-1,4,5-triphosphATE | ChEBI | Ins(1,4,5)P3 | ChEBI | InsP3 | ChEBI | IP3 | ChEBI | 1D-Myo-inositol 1,4,5-trisphosphate | Kegg | D-Myo-inositol 1,4,5-trisphosphoric acid | Generator | D-MYO-inositol-1,4,5-triphosphoric acid | Generator | 1D-Myo-inositol 1,4,5-trisphosphoric acid | Generator | Inositol 1,4,5-trisphosphoric acid | Generator | Myo-inositol 1,4,5-trisphosphate | HMDB | 1,4,5-IP3 | HMDB | Inositol 1,4,5-triphosphate | HMDB | Myoinositol 1,4,5-triphosphate | HMDB | D-myo-Inositol 1,4,5-triphosphate | HMDB | IP 3 | HMDB | Inositol 1,4,5-trisphosphate | HMDB | Inositol triphosphate | HMDB | Inositol trisphosphate | HMDB | Triphosphoinositol | HMDB | myo-Inositol 1,4,5-triphosphate | HMDB | myo-Inositol triphosphate | HMDB | myo-Inositol trisphosphate | HMDB |
|
---|
Chemical Formula | C6H15O15P3 |
---|
Average Molecular Mass | 420.096 g/mol |
---|
Monoisotopic Mass | 419.962 g/mol |
---|
CAS Registry Number | 85166-31-0 |
---|
IUPAC Name | {[(1R,2S,3R,4R,5S,6R)-2,3,5-trihydroxy-4,6-bis(phosphonooxy)cyclohexyl]oxy}phosphonic acid |
---|
Traditional Name | InsP3 |
---|
SMILES | O[C@@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H](O)[C@@H]1OP(O)(O)=O |
---|
InChI Identifier | InChI=1S/C6H15O15P3/c7-1-2(8)5(20-23(13,14)15)6(21-24(16,17)18)3(9)4(1)19-22(10,11)12/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1-,2+,3+,4-,5-,6-/m1/s1 |
---|
InChI Key | MMWCIQZXVOZEGG-XJTPDSDZSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as inositol phosphates. Inositol phosphates are compounds containing a phosphate group attached to an inositol (or cyclohexanehexol) moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Alcohols and polyols |
---|
Direct Parent | Inositol phosphates |
---|
Alternative Parents | |
---|
Substituents | - Inositol phosphate
- Monoalkyl phosphate
- Cyclohexanol
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Secondary alcohol
- Polyol
- Organic oxide
- Hydrocarbon derivative
- Aliphatic homomonocyclic compound
|
---|
Molecular Framework | Aliphatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-002b-7195200000-2871156f7c1e00704088 | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (3 TMS) - 70eV, Positive | splash10-0002-9052133000-5094b6ef55759c5a19dd | Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | Not Available | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-0006-0091000000-66258d5943e8e34a4f1b | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-00ba-9030000000-9567cb0f36d067bd98e8 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 13V, negative | splash10-0udi-0000900000-a08362b50609e7868113 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 19V, negative | splash10-0udi-0205900000-c9a653bc0177b1f5ec0c | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 20V, negative | splash10-0udi-1509800000-0c58a55629c8bdde91c4 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 25V, negative | splash10-0zi0-2709200000-f834442aa900d5925ee0 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 29V, negative | splash10-0kk9-6908000000-bce10d89581b945182c8 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 34V, negative | splash10-056r-9603000000-b83a25f979d90dcaacec | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 40V, negative | splash10-004i-9300000000-83996fe12a20b170e2dc | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 47V, negative | splash10-004i-9100000000-9c6fa50af864d3ab9ccc | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-0udi-0109000000-f750488015579ddac395 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-004i-9000000000-0ae8d2338f48c17984cd | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-0zfr-0970000000-d129d480332834af8631 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-004r-5900000000-4dffa7896e57b68d360e | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-08fr-0639000000-1fc55e97bbb62fd98506 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - n/a 29V, negative | splash10-0a4i-0943000000-4b6820f7da0e5d559167 | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 13V, negative | splash10-014i-0000900000-4422ae3f5c5cbce0813d | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 16V, negative | splash10-014i-0103900000-60bb04a7db68b52b301a | Spectrum | LC-MS/MS | LC-MS/MS Spectrum - Orbitrap 22V, negative | splash10-05fr-1409300000-c28e47a55145868de89d | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-00di-3008900000-e987cfb2603d94f1a6a4 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0uk9-2006900000-95047338604f8928313f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-00di-4291000000-8e9bb388f01ec6d535ab | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-014i-4001900000-395b5e207aa26dd43f27 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-004i-9003200000-5e6369906fdedd08ad60 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-004i-9000000000-4b72b937fe3bf7fe817e | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | DB03401 |
---|
HMDB ID | HMDB0001498 |
---|
FooDB ID | FDB022657 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | C00007460 |
---|
BiGG ID | 1485108 |
---|
BioCyc ID | INOSITOL-1-4-5-TRISPHOSPHATE |
---|
METLIN ID | 6282 |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Inositol trisphosphate |
---|
Chemspider ID | 388562 |
---|
ChEBI ID | 16595 |
---|
PubChem Compound ID | 439456 |
---|
Kegg Compound ID | C01245 |
---|
YMDB ID | YMDB00291 |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. Cooke, Allan M.; Potter, Barry V. L.; Gigg, Roy. Synthesis of DL-myo-inositol 1,4,5-trisphosphate. Tetrahedron Letters (1987), 28(20), 2305-8. | 2. Nibbering PH, Zomerdijk TP, van Haastert PJ, van Furth R: A competition binding assay for determination of the inositol (1,4,5)-trisphosphate content of human leucocytes. Biochem Biophys Res Commun. 1990 Jul 31;170(2):755-62. | 3. Brann JH, Dennis JC, Morrison EE, Fadool DA: Type-specific inositol 1,4,5-trisphosphate receptor localization in the vomeronasal organ and its interaction with a transient receptor potential channel, TRPC2. J Neurochem. 2002 Dec;83(6):1452-60. | 4. Poeckel D, Tausch L, Altmann A, Feisst C, Klinkhardt U, Graff J, Harder S, Werz O: Induction of central signalling pathways and select functional effects in human platelets by beta-boswellic acid. Br J Pharmacol. 2005 Oct;146(4):514-24. | 5. Koizumi H, Tanaka H, Ohkawara A: beta-Adrenergic stimulation induces activation of protein kinase C and inositol 1,4,5-trisphosphate increase in epidermis. Exp Dermatol. 1997 Jun;6(3):128-32. | 6. Eberhard M, Erne P: Inositol 1,4,5-trisphosphate-induced calcium release in permeabilized platelets is coupled to hydrolysis of inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate. Biochem Biophys Res Commun. 1993 Aug 31;195(1):19-24. | 7. Garlind A, Wiehager B, Winblad B, Fowler CJ: Intracellular inositol (1,4,5)-trisphosphate receptor levels are preserved in Alzheimer's disease platelets. Neurobiol Aging. 1997 Sep-Oct;18(5):559-61. | 8. Eberhard M, Erne P: Regulation of inositol 1,4,5-trisphosphate-induced calcium release by inositol 1,4,5-trisphosphate and calcium in human platelets. J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):297-309. | 9. Petersen OH, Burdakov D, Tepikin AV: Polarity in intracellular calcium signaling. Bioessays. 1999 Oct;21(10):851-60. | 10. Arranz B, Rosel P, Sarro S, Ramirez N, Duenas R, Cano R, Maria Sanchez J, San L: Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients. Psychiatry Res. 2003 May 30;118(2):165-74. | 11. Smith RJ, Justen JM, Nidy EG, Sam LM, Bleasdale JE: Transmembrane signaling in human polymorphonuclear neutrophils: 15(S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoic acid modulates receptor agonist-triggered cell activation. Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7270-4. | 12. Laffi G, Marra F, Failli P, Ruggiero M, Cecchi E, Carloni V, Giotti A, Gentilini P: Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides. Gastroenterology. 1993 Jul;105(1):148-56. | 13. Kalra R, Singh SP, Kracko D, Matta SG, Sharp BM, Sopori ML: Chronic self-administration of nicotine in rats impairs T cell responsiveness. J Pharmacol Exp Ther. 2002 Sep;302(3):935-9. | 14. Vanags DM, Lloyd JV, Rodgers SE, Bochner F: ADP, adrenaline and serotonin stimulate inositol 1,4,5-trisphosphate production in human platelets. Eur J Pharmacol. 1998 Sep 25;358(1):93-100. | 15. Saito H, Nishida A, Shimizu M, Motohashi N, Yamawaki S: Decreased inositol 1,4,5-trisphosphate-specific binding in platelets from alcoholic subjects. Biol Psychiatry. 1996 Nov 1;40(9):886-91. | 16. Suganuma A, Nakashima S, Okano Y, Nozawa Y: Mass contents of inositol 1,4,5-trisphosphate and 1,2-diacylglycerol in human platelets stimulated with a thromboxane analogue and thrombin. Thromb Haemost. 1992 Sep 7;68(3):341-5. | 17. Dwivedi Y, Janicak PG, Pandey GN: Elevated [3H]inositol 1,4,5-trisphosphate binding sites and expressed inositol 1,4,5-trisphosphate receptor protein level in platelets of depressed patients. Psychopharmacology (Berl). 1998 Jul;138(1):47-54. | 18. Willets JM, Nahorski SR, Challiss RA: Roles of phosphorylation-dependent and -independent mechanisms in the regulation of M1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons. J Biol Chem. 2005 May 13;280(19):18950-8. Epub 2005 Mar 2. | 19. Goncalves I, Hughan SC, Schoenwaelder SM, Yap CL, Yuan Y, Jackson SP: Integrin alpha IIb beta 3-dependent calcium signals regulate platelet-fibrinogen interactions under flow. Involvement of phospholipase C gamma 2. J Biol Chem. 2003 Sep 12;278(37):34812-22. Epub 2003 Jun 27. | 20. Santella L, Lim D, Moccia F: Calcium and fertilization: the beginning of life. Trends Biochem Sci. 2004 Aug;29(8):400-8. |
|
---|